SIASUN(SZ:300024) Sou Hu Cai Jing·2025-09-17 07:51Core Insights - Chengdu Kairui Medical Technology Co., Ltd. has completed a Pre-A+ round of financing, with a valuation exceeding 250 million yuan, following a previous investment from Luzhou Shuanggang Industrial Investment Development Co., Ltd. [1] - Kairui Medical specializes in multimodal humanoid medical robots, focusing on blood collection, ultrasound, and AI vision, with its core product being the intelligent blood collection robot (M series) [1][2]. Industry Pain Points and Market Opportunities - Blood collection is a critical operation in clinical diagnostics, providing key insights for over 70% of medical decisions, yet the industry faces a supply-demand imbalance with a market size exceeding 200 billion yuan [2]. - The industry relies heavily on manual operations, lacking mature products, and has a low penetration of automation, presenting a significant opportunity for technological advancements [2]. Product Features and Technology - Kairui Medical's blood collection robot aims to reduce pain and improve the speed and smoothness of the blood collection process, completing the procedure in approximately 90 seconds [4]. - The robot utilizes dual infrared and ultrasound technology to achieve high precision in blood vessel targeting, with a focus on sub-millimeter accuracy in puncture [5]. Data Accumulation and Product Optimization - The company is expanding its AI vision technology into multiple applications, including a collaboration with Beijing Scar Hospital to develop the S1 scar intelligent detection system, which quantifies scar characteristics [6]. - The recent financing will be used to establish clinical demonstration centers and accelerate data accumulation and product optimization, aiming for a new efficient medical scenario with self-service blood collection and rapid reporting [6]. User Acceptance and Comfort - Kairui Medical is addressing user concerns about robotic blood collection by incorporating engaging elements for children, such as playing cartoons during the procedure, and aims to develop a "pain-free needle" to enhance comfort [8]. - Research indicates that both adults and children generally report lower pain levels and higher acceptance after their first experience with robotic blood collection [8]. Future Prospects and Investment Outlook - Kairui Medical's technology has been validated at top international robotics conferences, reinforcing its reliability and cutting-edge status [9]. - Investors see significant potential in the automation of blood collection, which not only enhances medical efficiency but also improves patient experience, contributing to the broader development of smart healthcare ecosystems [9].